May 20, 2020 / 2:50 PM / 15 days ago

BRIEF-Vanda Pharmaceuticals CEO's Proposal On Clinical Trial Data Sharing, COVID-19 And Remdesivir

May 20 (Reuters) - Vanda Pharmaceuticals Inc:

* VANDA PHARMACEUTICALS CEO’S PROPOSAL ON CLINICAL TRIAL DATA SHARING, COVID-19 AND REMDESIVIR

* VANDA PHARMACEUTICALS - CURRENTLY IN PHASE III STUDIES WITH TRADIPITANT FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME ASSOCIATED WITH COVID-19

* VANDA PHARMA CEO SAYS REASON FOR SHARING OF DATA FOR COVID-19 TRAIL INCLUDES ALLOWING SCIENTIFIC COMMUNITY TO FORM OWN CONCLUSIONS FROM THEIR ANALYSES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below